Guidance and quality standards Awaiting development
Showing 1 to 6 of 6
Title | Type |
---|---|
Canagliflozin for treating type 2 diabetes in people 10 to 17 years TS ID 11888 | Technology appraisal guidance |
Dulaglutide for treating type 2 diabetes [ID1451] | Technology appraisal guidance |
Insulin icodec for treating type 1 and type 2 diabetes TS ID 11770 | Technology appraisal guidance |
Semaglutide for treating type 2 diabetes (ID1450) | Technology appraisal guidance |
Sotagliflozin for treating type 2 diabetes [ID1657] | Technology appraisal guidance |
Teplizumab for delaying the onset of type 1 diabetes in people 8 years and over at risk of developing the condition [ID6259] | Technology appraisal guidance |